ArticleInnovation (Cambridge (Mass.))2025

Adjuvant HAIC combined with anlotinib and TQB2450 for resected high-risk hepatocellular carcinoma.

Ning Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.